603 related articles for article (PubMed ID: 9206996)
1. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
3. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
4. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
Vinay DS; Kwon BS
Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
[TBL] [Abstract][Full Text] [Related]
5. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.
Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH
J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes.
Nam KO; Kang H; Shin SM; Cho KH; Kwon B; Kwon BS; Kim SJ; Lee HW
J Immunol; 2005 Feb; 174(4):1898-905. PubMed ID: 15699116
[TBL] [Abstract][Full Text] [Related]
7. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
[TBL] [Abstract][Full Text] [Related]
10. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
Cannons JL; Choi Y; Watts TH
J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
[TBL] [Abstract][Full Text] [Related]
11. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
[TBL] [Abstract][Full Text] [Related]
12. Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses.
Lee SW; Park Y; Song A; Cheroutre H; Kwon BS; Croft M
J Immunol; 2006 Oct; 177(7):4464-72. PubMed ID: 16982882
[TBL] [Abstract][Full Text] [Related]
13. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
Hurtado JC; Kim YJ; Kwon BS
J Immunol; 1997 Mar; 158(6):2600-9. PubMed ID: 9058792
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cord blood CD8+ T-cell effector differentiation by TGF-beta1 and 4-1BB costimulation.
Kim YJ; Stringfield TM; Chen Y; Broxmeyer HE
Blood; 2005 Jan; 105(1):274-81. PubMed ID: 15353478
[TBL] [Abstract][Full Text] [Related]
16. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
[TBL] [Abstract][Full Text] [Related]
17. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
May KF; Chen L; Zheng P; Liu Y
Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
[TBL] [Abstract][Full Text] [Related]
18. 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function.
Lee SJ; Myers L; Muralimohan G; Dai J; Qiao Y; Li Z; Mittler RS; Vella AT
J Immunol; 2004 Sep; 173(5):3002-12. PubMed ID: 15322159
[TBL] [Abstract][Full Text] [Related]
19. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.
Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB
Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
